Treatment strategies in patients with diabetes and three‐vessel coronary disease: What should we choose?
Open Access
- 11 February 2021
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Cardiovascular Diabetology
- Vol. 20 (1), 1-2
- https://doi.org/10.1186/s12933-021-01241-6
Abstract
The recent study demonstrating that percutaneous coronary intervention and coronary artery bypass grafting were associated with a lower risk of death and major adverse cardiac and cerebrovascular events (composite of all-cause death, myocardial infarction, or stroke) than with medical therapy among patients with diabetes and triple-vessel disease was very interesting. However, the nature of single-center nonrandomized and nonblinded studies that are not placebo controlled limits the extrapolation and generalizability of the results. As a result, the existing body of evidence does not fully support the use of revascularization treatment strategies in patients with diabetes and triple-vessel disease. Importantly, the safety of revascularization treatment strategies in this particular population remains uncertain. Therefore, further studies are needed to assess the risks and benefits of comprehensive treatment in these patients.Keywords
This publication has 8 references indexed in Scilit:
- Real-world outcomes of different treatment strategies in patients with diabetes and three-vessel coronary disease: a mean follow-up 6.3 years study from ChinaCardiovascular Diabetology, 2021
- Long-term outcomes of medical therapy versus successful recanalisation for coronary chronic total occlusions in patients with and without type 2 diabetes mellitusCardiovascular Diabetology, 2020
- Type 2 diabetes mellitus increases the mortality risk after acute coronary syndrome treated with coronary artery bypass surgeryCardiovascular Diabetology, 2020
- Chinese Herbal Medicine Dingji Fumai Decoction for Ventricular Premature Contraction: A Real-World TrialBioMed Research International, 2020
- High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitusCardiovascular Diabetology, 2019
- The role of coronary artery bypass surgery versus percutaneous intervention in patients with diabetes and coronary artery diseaseProgress in Cardiovascular Diseases, 2019
- Impact of type 2 diabetes mellitus on short- and long-term mortality after coronary artery bypass surgeryCardiovascular Diabetology, 2018
- Reassessing Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients with Type 2 Diabetes Mellitus: A Brief Updated Analytical Report (2015–2017)Diabetes Therapy, 2018